Feprosidnine
Feprosidnine is a stimulant drug that was developed in the Soviet Union in the 1970s. It is chemically related to the drug prosidnine and has been used for its nootropic and psychostimulant effects.
Chemical Structure and Properties[edit | edit source]
Feprosidnine is a derivative of prosidnine, with the chemical structure of 2-(2-furyl)-2-phenyl-2-(1-pyrrolidinyl)ethanol. It is a member of the pyrrolidine class of compounds, which are known for their stimulating effects on the central nervous system.
Pharmacology[edit | edit source]
Feprosidnine acts primarily as a dopamine reuptake inhibitor, which increases the levels of dopamine in the brain. This action is similar to that of other stimulant drugs such as methylphenidate and amphetamine. The increased dopamine levels are associated with enhanced cognitive function, improved memory, and increased alertness.
Medical Uses[edit | edit source]
Feprosidnine has been used in the treatment of various conditions, including attention deficit hyperactivity disorder (ADHD), narcolepsy, and certain types of depression. Its nootropic effects have also made it a subject of interest for enhancing cognitive performance in healthy individuals.
Side Effects[edit | edit source]
Common side effects of feprosidnine include insomnia, anxiety, headache, and nausea. In some cases, it may also cause tachycardia and hypertension. Long-term use can lead to tolerance, dependence, and addiction.
Legal Status[edit | edit source]
The legal status of feprosidnine varies by country. In some regions, it is classified as a controlled substance due to its potential for abuse and addiction. In others, it may be available by prescription for specific medical conditions.
Research[edit | edit source]
Research on feprosidnine has primarily focused on its potential as a cognitive enhancer and its effects on the central nervous system. Studies have shown that it can improve learning and memory in animal models, but more research is needed to fully understand its effects in humans.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
-
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
